Synthesis of 2,6,7-Trichloro-1-(β-D-ribofuranosyl)naphtho[2,3-d]imidazole: A Linear Dimensional Analogue of the Antiviral Agent TCRB

Journal of Organic Chemistry

Volumn 63, Issue 4, 1998, Pages 977-983

  Zhu, Zhijian ^a   Drach, John C ^a   Townsend, Leroy B ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 BROMO 5,6 DICHLORO 1 (BETA DEXTRO RIBOFURANOSYL)BENZIMIDAZOLE; 2,5,6 TRICHLORO 1 (BETA DEXTRO RIBOFURANOSYL)BENZIMIDAZOLE; 2,6,7 TRICHLORO 1 (BETA DEXTRO RIBOFURANOSYL)NAPHTHO[2,3 D]IMIDAZOLE; ANTIVIRUS AGENT; FOSCARNET; GANCICLOVIR; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; ARTICLE; BINDING SITE; DRUG SYNTHESIS; HUMAN CYTOMEGALOVIRUS; NUCLEAR OVERHAUSER EFFECT; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION;

EID: 0032548882     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo971152o     Document Type: Article

References (80)

1. Alford, C. A.; Britt, W. J. Cytomegalovirus. In The Human Herpesviruses; Roizman, B., Whitley, R. J., Lopez, C., Eds.; Raven Press: New York, 1993; pp 227-255.
2. Alford, C. A.; Stagno, S.; Pass, R. F.; Britt, W. J. Rev. Infect. Dis. 1990, 12, S745-S753.
3. Wingard, J. R.; Piantadosi, S.; Burns, W. H.; Zahurak, M. L.; Santos, G. W.; Saral, R. Rev. Infect. Dis. 1990, 12, S793-S804.
4. Rubin, R. H. Rev. Infect. Dis. 1990, 12, S754-S766.
5. Gallant, J. E.; Moore, R. D.; Richman, D. D.; Keruly, J.; Chaisson, R. E. J. Infect. Dis. 1992, 166, 1223-1227.
6. (a) Faulds, D.; Heel, R. C. Drugs 1990, 39, 597-638.
7. (b) Chrisp, P.; Clissold, S. P. Drugs 1991, 41, 104-129.
8. (c) Drew, W. L.; Lalezari, J. P.; Glutzer, E.; Lynch, T.; Flaherty, J.; Martin, J. C.; Fisher, P. E.; Jaffe, H. S. In Multidisciplinary Approach to Understanding Cytomegalovirus Disease; Michelson, S., Plotkin, S. A., Eds; Elsevier Science Publishers B. V.: New York, 1993; pp 287-292.
9. Field, A. K.; Biron, K. K. Clin. Microbiol. Rev. 1994, 7, 1-13.
10. (a) Millar, A. R.; Millar, R. F.; Patou, G.; Mindel, A.; Marsh, R.; Semple, S. J. G. Genitourin. Med. 1990, 66, 156-158.
11. (b) Prichard, M. M.; Prichard, L. E.; Baguley, W. A.; Nassiri, M. R.; Shipman, C., Jr. Antimicrob. Agents Chemther. 1991, 35, 1060-1065.
12. (a) Townsend, L. B.; Drach, J. C., and co-workers. Presented at the Fifth Int. Conf. Antiviral Res., Vancouver, BC, 1992, Abstracts 12, 105, 107, 108, 110.
13. (b) Townsend, L. B.; Devivar, R. V.; Turk, S. R.; Nassiri, M. R.; Drach, J. C. J. Med. Chem. 1995, 38, 4098-4105.
14. (c) Devivar, R. V.; Kawashima, E.; Revankar, G. R.; Breitenbach, J. M.; Freske, E. D.; Drach, J. C.; Townsend, L. B. J. Med. Chem. 1994, 37, 2942-2949.
15. (a) Underwood, M. R.; Biron, K. K.; Hemphill, M. L.; Miller, T. J.; Stanat, S. C.; Drach, J. C.; Townsend L. B.; Harvey, R. J. The Benzimidazole Riboside, 2-Bromo-5,6-dichloro-1-β-D-ribofuranosyl Benzimidazole (BDCRB), Prevents Maturation of Concatemeric Viral DNA in HCMV-Infected Cells. 4th International CMV Conference, Institut Pasteur, Paris, France, April 1993.
16. (b) Underwood, M. R.; Biron, K. K.; Hemphill, M. L.; Stanat, S. C.; Dornsife, R. E.; Drach, J. C.; Townsend L. B.; Edwards, C. A.; Harvey, R. J. High Molecular Weight HCMV DNA does not Properly Mature in the Presence of 2-Bromo-5,6-dichloro-1-β-D-ribofuranosylbenzimidazole (BDCRB). Herpesvirus Workshop, Pittsburgh, PA, July 1993.
17. (c) Underwood, M. R.; Stanat, S. C.; Drach, J. C.; Harvey, R. J.; Biron, K. K. Inhibition of HCMV DNA Processing by a new class of Anti-HCMV Compounds is Mediated through the UL89 Gene Product. Herpesvirus Workshop, Vancouver, B.C., August 1994.
18. (d) Underwood, M. R.; Stanat, S. C.; Townsend, L. B.; Drach, J. C.; Biron, K. K. Inhibition of HCMV DNA Processing by a New Class of Anti-HCMV Compounds (Benzimidazole Ribosides) is Mediated through the UL89 Gene Product. 8th International Conference on Antiviral Research, Santa Fe, NM, April 1995.
19. (a) Zou, R.; Ayres, K. R.; Drach, J. C.; Townsend, L. B. J. Med. Chem. 1996, 39, 3477-3482.
20. (b) Zou, R.; Drach, J. C.; Townsend, L. B. J. Med. Chem. 1997, 40, 811-818.
21. (c) Zou, R.; Drach, J. C.; Townsend, L. B. J. Med. Chem. 1997, 40, 802-810.
22. (a) Leonard, N. J.; Hiremath, S. P. Tetrahedron 1986, 42, 1917-1961.
23. (b) Leonard, N. J. Acc. Chem. Res. 1982, 15, 128-135.
24. (a) Renz, P.; Bauer-David, A. J. Z. Naturforsch. B Anorg. Chem. Org. Chem. Biochem. Biophys. Biol. 1972, 27, 539-544.
25. (b) Moder, K. P.; Leonard, N. J. J. Am. Chem. Soc. 1982, 104, 2613-2624.
26. (c) Stevenson, T. M.; Leonard, N. J. J. Org. Chem. 1984, 49, 2158-2164.
27. (a) Tominaga, Y.; Lee, M. L.; Castle, R. N. J. Heterocycl. Chem. 1981, 18, 967-972.
28. (b) Dozen, Y.; Hatta, M. Bull. Chem. Soc. Jpn. 1975, 48, 2842-2847.
29. (a) Duschinsky, R.; Dolan, L. A. J. Am. Chem. Soc. 1946, 68, 2350-2355.
30. (b) Huines, D. R.; Leonard, N. J.; Wiemer, D. F. J. Org. Chem. 1982, 47, 478-482.
31. (a) Grimmett, M. R. in Comprehensive Heterocyclic Chemistry; Katritzky, A., Rees, C., Eds.; Pergamon Press: New York, 1984; Vol. 5, p 402.
32. (b) Schnettler, R. A.; Dage, R. C.; Grisar, J. M. J. Med. Chem. 1982, 25, 1477-1481.
33. McMurry, J. E.; Musser, J. H. Org. Synth. 1977, 56, 65-68.
34. Reviews on the generation of o-quinodimethanes: (a) Martin, N.; Seoane, C.; Hanack, M. Org. Prepr. Proced. Int. 1991, 23, 239-272. (b) Charlton, J. L.; Alauddin, M. M. Tetrahedron 1987, 43, 2873-2889. (c) Oppolzer, W. In Comprehensive Organic Synthesis; Trost, B. M., Fleming, I., Eds.; Pergamon Press: New York, 1991; Vol. 5, pp 385-396. (d) Oppolzer, W. Synthesis 1978, 793-795.
35. Reviews on the generation of o-quinodimethanes: (a) Martin, N.; Seoane, C.; Hanack, M. Org. Prepr. Proced. Int. 1991, 23, 239-272. (b) Charlton, J. L.; Alauddin, M. M. Tetrahedron 1987, 43, 2873-2889. (c) Oppolzer, W. In Comprehensive Organic Synthesis; Trost, B. M., Fleming, I., Eds.; Pergamon Press: New York, 1991; Vol. 5, pp 385-396. (d) Oppolzer, W. Synthesis 1978, 793-795.
36. Reviews on the generation of o-quinodimethanes: (a) Martin, N.; Seoane, C.; Hanack, M. Org. Prepr. Proced. Int. 1991, 23, 239-272. (b) Charlton, J. L.; Alauddin, M. M. Tetrahedron 1987, 43, 2873-2889. (c) Oppolzer, W. In Comprehensive Organic Synthesis; Trost, B. M., Fleming, I., Eds.; Pergamon Press: New York, 1991; Vol. 5, pp 385-396. (d) Oppolzer, W. Synthesis 1978, 793-795.
37. Reviews on the generation of o-quinodimethanes: (a) Martin, N.; Seoane, C.; Hanack, M. Org. Prepr. Proced. Int. 1991, 23, 239-272. (b) Charlton, J. L.; Alauddin, M. M. Tetrahedron 1987, 43, 2873-2889. (c) Oppolzer, W. In Comprehensive Organic Synthesis; Trost, B. M., Fleming, I., Eds.; Pergamon Press: New York, 1991; Vol. 5, pp 385-396. (d) Oppolzer, W. Synthesis 1978, 793-795.
38. Durst, T.; Greau, L. in Comprehensive Organic Synthesis; Trost, B. M., Fleming, I., Eds.; Pergamon Press: New York, 1991; Vol. 5, pp 691-696.
39. (a) Wasserman, H. H.; Solodar, J. J. Am. Chem. Soc. 1965, 87, 4002-4003.
40. (b) Bubb, W. A.; Sternhell, S. Aust. J. Chem. 1976, 29, 1685-1697.
41. (a) Stiles, M.; Miller, R. G.; Burckharclt, U. J. Am. Chem. Soc. 1963, 85, 1792-1797.
42. (b) Friedman, L.; Logullo, F. M. J. Am. Chem. Soc. 1963, 85, 1549.
43. (c) Logullo, F. M.; Seize, A. H.; Friedman, L. Org. Synth. 1968, 48, 12-17.
44. (d) Frideman, L.; Logullo, F. M. J. Org. Chem. 1969, 34, 3089-3092.
45. (e) Roberts, R. M.; Gilgert, J. C.; Rodewald, L. B.; Wingrove. A. S. An introduction to modern experimental organic chemistry; Holt, Rinehart and Winston, New York, 1969; pp 196-201.
46. (f) Ardakan, M. A.; Wallace, T. W. Tetrahedron 1988, 44, 5939-5952.
47. Ito, Y.; Nakatsuka, M.; Saegusa, T. J. Am. Chem. Soc. 1982, 104, 7609-7622.
48. (a) Han, B. H.; Boudjouk, P. J. Org. Chem. 1982, 47, 751-752.
49. (b) Rubottom, G. M.; Wey, J. E. Synth. Commun. 1984, 14, 507-513.
50. (c) Inaba, S.; Wehmeyer, R. M.; Forker, M. W.; Reike, R. D. J. Org. Chem. 1988, 53, 339-344.
51. Levy, L. Synth. Commun. 1983, 13, 639-648.
52. (a) Jung, F.; Molin, M.; Van Den Elzen, R.; Durst, T. J. Am. Chem. Soc. 1974, 96, 935-936.
53. (b) Charlton, J. L.; Durst, T. Tetrahedron Lett. 1984, 25, 5287-5290.
54. (c) Durst, T.; Charlton, J. L. Can. J. Chem. 1986, 64, 246-249.
55. (d) Harpp, D. N.; Steliou, K.; Chan, T. H. J. Am. Chem. Soc. 1978, 100, 1222-1228.
56. (e) Hoey, M. D.; Dittmer, D. C. J. Org. Chem. 1991, 56, 1947-1948.
57. (f) Attarde, G.; Wang, W.; Kraus, J.-L.; Belleau, B. Tetrahedron Lett. 1994, 55, 4743-4746.
58. We were quite surprised to find that this method has not been used for the generation of other sulfinates, except 1,4-dihydro-2,3-benzoxathiin 3-oxide, and to some extent has been neglected (see ref 25f).
59. (a) For a general review on aromatization: Fu, P. P.; Harvey, R. G. Chem. Rev. 1978, 78, 317-360.
60. (b) Barnes, R. A. J. Am. Chem. Soc. 1948, 70, 145-147.
61. (c) Braude, E. A.; Brook, A. G.; Linstead, R. P. J. Chem. Soc. 1954, 3, 569-573.
62. (d) Fu, P. P.; Harvey, R. G. Tetrahedron Lett. 1974, 36, 3217-3220.
63. (e) Martin, N.; Bechard, R.; Hanack, M. J. Org. Chem. 1984, 54, 2563-2568.
64. Ono, N. The nitro function as a leaving group in organic synthesis. In Nitro Compounds, Recent Advances in Synthesis and Chemistry; Feuer, H., Nieken, A. T., Eds.; VCH Publisher: New York, 1990; pp 1-127.
65. Vorbruggen method: (a) Vorbruggen, H.; Krotikiewicz, K.; Bennua, B. Chem. Ber. 1981 114, 1234-1255. (b) Vorbruggen, H.; Bennua, B. Chem. Ber. 1981, 114, 1279-1286. (c) Dudycz, L.; Wright, G. E. Nucleosides Nudeotides 1984, 3, 33-44.
66. Vorbruggen method: (a) Vorbruggen, H.; Krotikiewicz, K.; Bennua, B. Chem. Ber. 1981 114, 1234-1255. (b) Vorbruggen, H.; Bennua, B. Chem. Ber. 1981, 114, 1279-1286. (c) Dudycz, L.; Wright, G. E. Nucleosides Nudeotides 1984, 3, 33-44.
67. Vorbruggen method: (a) Vorbruggen, H.; Krotikiewicz, K.; Bennua, B. Chem. Ber. 1981 114, 1234-1255. (b) Vorbruggen, H.; Bennua, B. Chem. Ber. 1981, 114, 1279-1286. (c) Dudycz, L.; Wright, G. E. Nucleosides Nudeotides 1984, 3, 33-44.
68. Revankar, G. R.; Robins, R. K. Nucleosides and Nucleotides 1989, 8, 709-724.
69. Earl, R. A.; Townsend, L. B. In Nucleic Acid Chemistry, Improved and New Synthetic Procedures, Methods and Techniques; Wiley Interscience: New York, N.Y., 1991, Townsend, L. B., Tipson, R. S., Eds.; Part 1, pp 203-205.
70. However, successful examples of ribosylation of 2-oxo derivatives in benzimidazole, imidazo[4,5-6]qumoline, and imidazo[4, 5-b]-quinoxaline systems have been observed, (a) Reference 9b. (b) Zhu, Z.; Townsend, L. B. Unpublished results.
71. However, successful examples of ribosylation of 2-oxo derivatives in benzimidazole, imidazo[4,5-6]qumoline, and imidazo[4, 5-b]-quinoxaline systems have been observed, (a) Reference 9b. (b) Zhu, Z.; Townsend, L. B. Unpublished results.
72. Seela, F.; Bussmann, W. Nucleosides Nucleotides 1982, 1, 253-261.
73. Mead, E. A.; Wotring, L. L.; Drach, J. C.; Townsend, L. B. J. Med. Chem. 1993, 36, 3834-3842.
74. (a) Hijazi, A.; Pfleiderer, W. Nucleosides Nucleotides 1984, 13, 293-295.
75. (b) Hijazi, A. Nucleosides Nucleotides 1986, 5, 529-537.
76. (c) Hijazi, A. Nucleosides Nucleotides 1988, 7, 537-547.
77. (a) Robins, R. K. J. Am. Chem. Soc. 1960 82, 2654-2655.
78. (b) Gerster, J. F.; Jones, J. W.; Robins, R. K. J. Org. Chem. 1963, 28, 945-948.
79. (c) Rousseau, R. J.; Robins, R. K.; Townsend, L. B. J. Am. Chem. Soc. 1968, 90, 2661-2668.
80. (d) Giner-Sorolla, A.; Nanos, C.; Burchenal, J. H.; Dollinger, M.; Bendich, A. J. Med. Chem. 1968, 11, 52-54.